The FDA has issued approval for a drug that can slow down the progress of Alzheimer's in some patients in the early stages of the disease.
On Thursday, the FDA issued approval for a drug that can slow down the progress of Alzheimer's in some patients in the early stages of the disease. It's called "Leqembi."It's not a cure, but FOX 32 spoke to a Rush University neurologist, who says this gives families one option to try to gain more time with their loved ones.
Dr. Augusto Miravalle points out that since this drug is only effective in patients in the very early stages of Alzheimer's, it's more important than ever for families to recognize the earliest signs of the disease.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
FDA grants full approval to new Alzheimer's drug meant to slow diseaseBREAKING: FDA grants full approval of Alzheimer’s drug Leqembi, amid concerns about its safety, cost and accessibility. The move marks the first time that a drug meant to slow the progression of the disease has been granted full regulatory approval.
Read more »
FDA Approves Promising New Alzheimer’s Drug LeqembiNot only is it the first Alzheimer’s antibody treatment to get full FDA approval, it’s also the first that will be broadly covered by Medicare.
Read more »
FDA Approves New Drug to Slow Alzheimer's DiseaseThe FDA today approved a new therapy for early Alzheimer's disease that appears to modestly slow the progression of the disease that affects more than 6.5 million Americans.
Read more »
FDA Approves New Drug to Slow Alzheimer’s DiseaseThe FDA today approved a new therapy for early Alzheimer’s disease that appears to modestly slow the progression of the disease that affects more than 6.5 million Americans.
Read more »
FDA approves use of Leqembi to treat Alzheimer's patientsFDA approves use of Leqembi Alzheimer\u0027s patients
Read more »
FDA to grant full approval for Alzheimer's medication LecanemabIf the FDA grants Lecanemab full approval, medical experts say Medicaid and Medicare will likely cover it MORE ⬇️
Read more »